Navigation Links
Simbionix ANGIO Mentor Plays Important Role in Physician Training and Certification
Date:5/18/2010

CLEVELAND, Ohio, May 18, 2010 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is proud to report that their ANGIO Mentor virtual reality simulator was used during the 4th International Congress of the Polish Vascular Societies in April 2010 for the training and certification of vascular physicians from medical centers across Poland.

The congress was organized by the Polish Society of Angiology, the Interventional Radiology Section of the Polish Medical Society of Radiology and the Polish Society of Vascular Surgery. The scientific program covered vascular and endovascular issues including patient management during and after the intervention, vascular malformations and children's vascular surgery. During the congress learners gained hands on practice on the ANGIO Mentor.

The Simbionix ANGIO Mentor is a multidisciplinary simulator that provides a complete and true-to-life simulated environment for hands-on practice of interventional endovascular procedures. During the sessions, which were led by key opinion leaders in the field of endovascular procedures in Poland, the physicians used the Simbionix simulators to train and exhibit proficiency in various procedures. Attendees who completed one full endovascular procedure and demonstrated their knowledge and skills in the case steps received certification from the Polish Vascular Society. Training sessions utilized the various practice opportunities offered by the ANGIO Mentor including: carotid stenting, iliac & SFA interventions, renal arteries interventions, as well as virtual abdominal aortic aneurism repairs.

Ran Bronstein, Simbionix President, commented that "The inclusion of the Simbionix ANGIO Mentor in this recent training and certification are a great example of our simulator's benefits in providing a hands-on aspect to practicing patient management and procedure understanding, as well as providing an excellent tool to track learners' records and provide objective assessment. Realistic true to life simulation will be a key factor in the certification of physicians in the future, and we expect such inclusion to become more evident in medical training around the world."

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes. Simbionix cooperates with physicians on a regular basis to produce the most reliable and effective training and supporting systems.

    For more information on Simbionix, visit http://www.simbionix.com

    Contact:

    Rebecca Zitter
    Manager of Marketing Communications and Distributor Relations
    Rebecca@simbionix.com
    Tel: +1-216-229-2040



'/>"/>
SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies
2. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
3. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
4. Simbionix Increases Product Offerings for OB/GYN Physicians
5. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
6. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
7. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
8. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
9. Simbionix Launches Innovative Patient-Specific Simulation
10. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
11. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... ProMIS Neurosciences (“ProMIS” ... first three targets, it has identified a fourth in a series of novel ... development and progression of Alzheimer’s disease (AD). , “This discovery is ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Proove Biosciences, ... announce a strategic partnership with McGill University . The partnership is designed to ... market in order to help patients in pain. With the new agreement, researchers at ...
(Date:5/4/2016)... York , May 4, 2016 ... Transparency Market Research "Metabolomics Market - Global Industry Analysis, ... the metabolomics market is anticipated to expand at a ... USD 2,494.8 million by 2024. Metabolomics is ... metabolites, within cells, biofluids, tissues or organisms. Together, these ...
(Date:5/3/2016)... , May 3, 2016 ... Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip ... user (Academics Institutes, Diagnostics Centers), Fabrication Technology ... by MarketsandMarkets, the market is expected to ... USD 7.63 Billion in 2015, growing at ...
Breaking Biology Technology:
(Date:3/11/2016)... India , March 11, 2016 ... a new market research report "Image Recognition Market by ... Application (Marketing and Advertising), by Deployment Type (On-Premises and ... Forecast To 2022", published by MarketsandMarkets, the global market ... 2015 to USD 29.98 Billion by 2020, at a ...
(Date:3/9/2016)... March 9, 2016 This BCC Research report ... of the RNA Sequencing (RNA Seq) market for the ... instruments, tools and reagents, data analysis, and services. ... of the RNA-Sequencing market such as RNA-Sequencing tools and ... main factors affecting each segment and forecast their market ...
(Date:3/8/2016)... , March 8, 2016   Valencell , ... today announced it has secured $11M in Series ... Tech, a new venture fund being launched by ... participation from existing investors TDF Ventures and WSJ ... to continue its triple-digit growth and accelerate its ...
Breaking Biology News(10 mins):